Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) went down by -0.55% from its latest closing price compared to the recent 1-year high of $23.25. The company’s stock price has collected -5.40% of loss in the last five trading sessions.
Is It Worth Investing in Allscripts Healthcare Solutions Inc. (NASDAQ :MDRX) Right Now?
Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) scored a price-to-earnings ratio above its average ratio, recording 19.16 x from its present earnings ratio. Plus, the 36-month beta value for MDRX is at 1.02.
MDRX currently public float of 106.64M and currently shorts hold a 8.28% ratio of that float. Today, the average trading volume of MDRX was 1.32M shares.
MDRX’s Market Performance
MDRX stocks went down by -5.40% for the week, with a monthly drop of -0.11% and a quarterly performance of 26.53%, while its annual performance rate touched 5.19%. The volatility ratio for the week stands at 2.75% while the volatility levels for the past 30 days are set at 2.80% for Allscripts Healthcare Solutions Inc. The simple moving average for the period of the last 20 days is -1.07% for MDRX stocks with a simple moving average of 4.49% for the last 200 days.
Analysts’ Opinion of MDRX
Many brokerage firms have already submitted their reports for MDRX stocks, with Argus repeating the rating for MDRX by listing it as a “Buy.” The predicted price for MDRX in the upcoming period, according to Argus is $26 based on the research report published on December 07th of the previous year 2022.
Goldman, on the other hand, stated in their research note that they expect to see MDRX reach a price target of $23, previously predicting the price at $22. The rating they have provided for MDRX stocks is “Buy” according to the report published on November 09th, 2022.
Piper Sandler gave a rating of “Overweight” to MDRX, setting the target price at $17 in the report published on November 04th of the previous year.
MDRX Trading at -1.76% from the 50-Day Moving Average
After a stumble in the market that brought MDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.88% of loss for the given period.
Volatility was left at 2.80%, however, over the last 30 days, the volatility rate increased by 2.75%, as shares surge +0.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.38% lower at present.
During the last 5 trading sessions, MDRX fell by -2.38%, which changed the moving average for the period of 200-days by -20.42% in comparison to the 20-day moving average, which settled at $18.13. In addition, Allscripts Healthcare Solutions Inc. saw 2.21% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at MDRX starting from Vakharia Tejal, who sale 8,642 shares at the price of $18.42 back on Dec 12. After this action, Vakharia Tejal now owns 222,604 shares of Allscripts Healthcare Solutions Inc., valued at $159,193 using the latest closing price.
Stevens David B, the Director of Allscripts Healthcare Solutions Inc., sale 43,134 shares at $18.47 during a trade that took place back on Dec 06, which means that Stevens David B is holding 32,384 shares at $796,827 based on the most recent closing price.
Stock Fundamentals for MDRX
Current profitability levels for the company are sitting at:
- +5.79 for the present operating margin
- +38.28 for the gross margin
The net margin for Allscripts Healthcare Solutions Inc. stands at +8.91. Equity return is now at value 4.70, with 2.90 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.39.